Literature DB >> 8825798

Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease.

Y Yamashiro1, S Nagata, S Oguchi, T Shimizu.   

Abstract

The current study tested the hypothesis that the gastrointestinal tract could be one of the primary sites of entry for etiologic agents in Kawasaki disease (KD). In an attempt to elucidate the pathogenic role of certain superantigenic agents in KD, T cell receptor V beta expression by T cells in the small intestinal mucosa of KD patients was investigated using MAb on frozen tissue sections. Twelve Japanese patients with KD and eight controls were enrolled in the study. The numbers of cells stained by an immunofluorescence from each study group were counted and analyzed statistically by the t test. The occurrence of V beta 2+ T cells was found to be selectively increased in the small intestinal mucosa of patients in the acute phase of KD compared with controls (p < 0.01). In our previous study, five kinds of streptococci and two kinds of staphylococci, not detected in control patients, were isolated from the lumen of the jejunum of KD patients. These data suggest that the increased occurrence of V beta 2+ T cells in the jejunal mucosa of KD patients may be caused by exotoxins acting as superantigens produced by bacteria colonizing the small intestinal mucosa of these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825798     DOI: 10.1203/00006450-199602000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

3.  T cell Vbeta repertoires in childhood vasculitides.

Authors:  P A Brogan; V Shah; A Bagga; N Klein; M J Dillon
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

5.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

6.  Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.

Authors:  Magdalena F Natividad; Celia Aurora T Torres-Villanueva; Cynthia P Saloma
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

Review 7.  The systemic and pulmonary immune response to staphylococcal enterotoxins.

Authors:  Sanjeev Kumar; Antoine Ménoret; Soo-Mun Ngoi; Anthony T Vella
Journal:  Toxins (Basel)       Date:  2010-07-21       Impact factor: 4.546

Review 8.  The role of infection in Kawasaki syndrome.

Authors:  Nicola Principi; Donato Rigante; Susanna Esposito
Journal:  J Infect       Date:  2013-04-18       Impact factor: 6.072

9.  Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease.

Authors:  Satoru Nagata; Yuichiro Yamashiro; Yoshikazu Ohtsuka; Toshiaki Shimizu; Yumiko Sakurai; Shigeki Misawa; Teruyo Ito
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

10.  Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?

Authors:  Marianna Fabi; Elena Corinaldesi; Luca Pierantoni; Elisa Mazzoni; Chiara Landini; Barbara Bigucci; Gina Ancora; Laura Malaigia; Tetyana Bodnar; Giorgia Di Fazzio; Francesca Lami; Enrico Valletta; Cristina Cicero; Giacomo Biasucci; Lorenzo Iughetti; Federico Marchetti; Paola Sogno Valin; Sergio Amarri; Sandra Brusa; Monica Sprocati; Giuseppe Maggiore; Ada Dormi; Paolo Lanzoni; Andrea Donti; Marcello Lanari
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.